Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051928 | PMC |
| http://dx.doi.org/10.1165/rcmb.2024-0332LE | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Developing Community-Informed Communication Resources to Improve Human Papillomavirus Vaccine Uptake in Tonga.
Health Expect
October 2025
Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Introduction: Despite high coverage of routine childhood vaccines, uptake of the human papillomavirus (HPV) vaccine in the Pacific Island nation of Tonga has been slow. Culturally appropriate communication resources on the importance, safety, and effectiveness of the HPV vaccine are critical to support acceptance and uptake. To develop these resources, it is important to understand what people want to know.
View Article and Find Full Text PDFElectrocardiographic P-wave peak time predicts significant ischemia in INOCA patients: A pilot study.
J Electrocardiol
August 2025
Department of Cardiology, Kırşehir Ahi Evran Training and Research Hospital, Kırşehir, Turkey. Electronic address:
Background: Ischemia with non-obstructive coronary arteries (INOCA) represents a diagnostic and therapeutic challenge, often related to coronary microvascular dysfunction (CMD). Identifying non-invasive electrocardiographic markers that predict ischemia in this population remains a clinical priority. P-wave peak time (PWPT), reflecting atrial conduction delay, has been linked to ischemic pathophysiology.
View Article and Find Full Text PDFBridging the gap: Analysis of the long school of medicine SNMA pilot mentorship program.
J Natl Med Assoc
September 2025
Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Importance: Underrepresented in medicine (URiM) students face significant barriers in medical education, including limited access to mentorship and professional networks. Mentorship is a critical factor in improving academic outcomes, career satisfaction, and overall success, highlighting the need for targeted support programs that broaden access in medical training.
Objective: To develop and evaluate a longitudinal four-year faculty-student dyad mentorship program to provide mentorship for URiM students, focusing on enhancing academic integration, professional networking, and career development.
Optimization of ciliary body cyclophotocoagulation settings: a randomized and controlled pilot study.
Can J Ophthalmol
September 2025
Département d'Ophtalmologie et d'Ophtalmologie et d'Oto-Rhino-Laryngologie-Chirurgie Cervico-Faciale, Faculté de Médecine, Université Laval, QC, Canada; Centre Universitaire d'Ophtalmologie, Hôpital du Saint-Sacrement, Centre Hospitalier Universitaire de Québec-Université Laval, QC, Canada.
Objective: To compare the efficacy of different settings in continuous-wave transscleral cyclophotocoagulation (CW-TSCPC).
Design: Prospective, randomized, triple-blind clinical trial in a single tertiary center.
Participants: Adult glaucoma patients who need continuous wave-transscleral cyclophotocoagulation to control intraocular pressure (IOP) or prevent or treat ocular pain/discomfort secondary to increased IOP.
PD-L1 expression in locally advanced cervical cancer: A pilot cross clone comparison study.
Int J Radiat Oncol Biol Phys
September 2025
Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Electronic address:
Purpose: Recent immunotherapy trials in locally advanced cervical cancer report high PD-L1 positivity rates whereas academic multicentric initiatives report a lower PD-L1 positivity. These observations necessitate cross-clone comparison to understand the observed differences.
Methods: Two different clones used in previous multicentric international studies SP142 (BIOEMBRACE) and 22C3 (KEYNOTE-A18) were used to test PD-L1 positivity in a pilot cohort of FIGO 2018 stage III cervical cancer patients recruited in a phase III trial.